- Previous close
0.0450 - Open
0.0480 - Bid 0.0490 x --
- Ask 0.1500 x --
- Day's range
0.0480 - 0.0480 - 52-week range
0.0300 - 0.1850 - Volume
1,000 - Avg. Volume
23 - Market cap (intra-day)
6.336M - Beta (5Y monthly) --
- PE ratio (TTM)
4.80 - EPS (TTM)
0.0100 - Earnings date --
- Forward dividend & yield --
- Ex-dividend date --
- 1y target est
--
Pasture Holdings Ltd. operates a pharmaceutical products and medical supplies and devices company in Singapore, Japan, Malaysia, Hong Kong, Canada, United Kingdom, and internationally. It operates through three segments: Pharmaceutical Wholesale and Drop-Shipment, Masks and Medical Supplies, and Other Services. The company develops, markets, and sells Pasture masks, including surgical masks, N95 respirators, and surgical N95 respirators. It also engages in the wholesale procurement and transshipment of pharmaceutical and nutraceutical products, such as vaccines, oncology products, and medical aesthetics products, as well as pet pharmaceutical and nutraceutical products. Ina addition, the company markets and sells oral disintegrating strips and the pet pharmaceutical and nutraceutical products and services.; and provides furlife, a mobile application that provides a suite of pet health and nutrition services for pet owners. The company was founded in 1996 and is based in Singapore.
pasturegroup.com--
Full-time employees
30 June
Fiscal year ends
Healthcare
Sector
Medical Distribution
Industry
Related news
View more
Performance overview: UUK.SI
Trailing total returns as of 04/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: UUK.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: UUK.SI
View moreValuation measures
Market cap
5.94M
Enterprise value
2.61M
Trailing P/E
8.10
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.32
Price/book (mrq)
1.02
Enterprise value/revenue
0.14
Enterprise value/EBITDA
1.92
Financial highlights
Profitability and income statement
Profit margin
3.97%
Return on assets (ttm)
2.90%
Return on equity (ttm)
13.61%
Revenue (ttm)
14.06M
Net income avi to common (ttm)
559k
Diluted EPS (ttm)
0.0100
Balance sheet and cash flow
Total cash (mrq)
4.74M
Total debt/equity (mrq)
47.09%
Levered free cash flow (ttm)
135.75k